LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged patent protection · clear

Patent Prosecution

Bipartisan Draft Bill to Amend Ss 100 101 and 112 Released for Comment

On Wednesday, Senators Tillis and Coons, along with Reps. Collins, Johnson and Stivers released a draft, bipartisan bill to amend ss.100 and 101 to void the “judicial exceptions” to patent eligibility. Section 112(f) was also amended to tighten…

May 27, 2019·Patent Prosecution·4 min read
Unsorted

Do You Really Want to File for Pharma Patent Protection in Canada, India or Ecuador?

IPO Letter Reports Weaknesses in IP Protection Around the World In a 27 page letter dated February 8, 2018 and sent to Sue Chang at the Office of the U.S. Trade Representative, the Executive Director of IPO, Mark Lauroesch, extensively summarizes the flaws…

February 16, 2018·Unsorted·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.